Gardner Lewis Asset Management’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Gardner Lewis Asset Management’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-25,000	Closed	-$1.5M	–	103
2021 Q1	$1.5M	Buy	+25,000	New	+$905K	0.27%	73

Gardner Lewis Asset Management's PAND Position: Q2 2021 in Review

Gardner Lewis Asset Management sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 25,000 shares — an estimated $1.5M sold.

Gardner Lewis Asset Management first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $1.5M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Gardner Lewis Asset Management reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Gardner Lewis Asset Management sold 25,000 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $1.5M.
Gardner Lewis Asset Management first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
Gardner Lewis Asset Management's Pandion Therapeutics Inc. Common Stock position peaked at $1.5M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Gardner Lewis Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.